ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Rejection Triggers Liver Transplant Tolerance: Involvement of Mesenchyma-Meidated Immune Control Mechanisms

M. Morita, D. Joyce, C. Miller, J. Fung, L. Lu, S. Qian.

Immunology, Lerner Research Institute
2General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

Meeting: 2015 American Transplant Congress

Abstract number: 111

Keywords: Graft survival, Hyporeactivity, Immune deviation, Liver transplantation

Session Information

Session Name: Concurrent Session: Liver Transplant Rejection: Animal Models

Session Type: Concurrent Session

Date: Sunday, May 3, 2015

Session Time: 4:00pm-5:30pm

 Presentation Time: 4:00pm-4:12pm

Location: Room 121-AB

Successful organ transplantation relies on lifelong immunosuppression, associated with severe side effects. Induction of tolerance is ideal but elusive in clinic. Indeed spontaneous liver transplant tolerance occurs frequently in both animals and humans with unclear mechanism. We were inspired by an unexpected phenomenon that the liver transplant tolerance absolutely requires rejection cytokine interferon (IFN)-γ and investigated the rejection of IFN-γ receptor knockout liver allograft in WT recipients. We revealed that the rejection of IFN-γR1-/- liver graft is not mediated by graft CD45+ hematopoietic immune cells because they rapidly replaced by WT cells of recipient origin. It is rather mediated by the graft CD45– mesenchymal cells. IFN-γ (derived from T effectors (Tef) cells) ligation on graft mesenchymal cells triggers the upregulation of B7-H1expression leading to the apoptosis of the infiltrating Tefs. This documentes that the allograft equips machinery to counterattack the host immune response through mesenchyma-mediated immune control (MMIC) mechanism. The MMIC represents the intrinsic negative feedback loop cascades between graft mesenchymal cells and effector T cells leading to liver tolerance. Comparable elevations of Treg cells and MDSC are seen in both rejection and tolerance groups, suggesting a critical role of Tef cell elimination in tolerance induction. We identify potent MMIC activity in hepatic stellate cells (HpSC) and liver sinusoid endothelial cells (LSEC). Addition of either HpSC or LSEC markedly suppresses T cell response in MLR cultures. Co-transplantation with HpSC or LSEC significantly prolongs survival of islet allografts. HpSC isolated from IFN-γR-/- or B7-H1-/- mice fail to protect the co-transplanted islet allografts, indicating critical role of IFN-γ/B7-H1 signaling pathway in immune regulation. Inhibitory activity of MMCI is unlikely exclusive to the liver, as spontaneous acceptance of kidney allograft has been reported, although less common, probably reflecting variance in MMIC activity between individual organs. MMIC may represent an important homeostatic mechanism that supports peripheral tolerance. MMIC orchestrated by the allograft may represent a novel target for the induction of transplant tolerance. Graft plays a key role in the equipoise between tolerance and rejection and warrants attention in the search for biomarkers of tolerance.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Morita M, Joyce D, Miller C, Fung J, Lu L, Qian S. Rejection Triggers Liver Transplant Tolerance: Involvement of Mesenchyma-Meidated Immune Control Mechanisms [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/rejection-triggers-liver-transplant-tolerance-involvement-of-mesenchyma-meidated-immune-control-mechanisms/. Accessed May 19, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences